Effects of exercise and creatine on myosin heavy chain isoform composition in patients with Charcot-Marie-Tooth disease

Muscle and Nerve

Volumn 34, Issue 5, 2006, Pages 586-594

  Smith, Cheryl A ^a   Chetlin, Robert D ^a   Gutmann, Laurie ^a   Yeater, Rachel A ^a   Alway, Stephen E ^a  

^a WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Charcot Marie Tooth disease; Creatine; Exercise; Myosin heavy chain; Neuromuscular disease; Nutritional supplement; Skeletal muscle

Indexed keywords

CREATINE; GLUCOSE; ISOPROTEIN; MYOSIN HEAVY CHAIN; MYOSIN I; MYOSIN IIA; NEOTINE; PLACEBO;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DOUBLE BLIND PROCEDURE; EXERCISE; FEMALE; FUNCTION TEST; GEL ELECTROPHORESIS; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; HYPOTHESIS; MALE; MUSCLE BIOPSY; MUSCLE FUNCTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; SUPPLEMENTATION; VASTUS LATERALIS MUSCLE;

ADULT; BIOPSY; CHARCOT-MARIE-TOOTH DISEASE; CREATINE; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; EXERCISE TEST; EXERCISE THERAPY; EXERCISE TOLERANCE; HUMANS; MIDDLE AGED; MUSCLE CONTRACTION; MUSCLE, SKELETAL; MYOSIN HEAVY CHAINS; PHYSICAL FITNESS; PROTEIN ISOFORMS; QUADRICEPS MUSCLE; TREATMENT OUTCOME;

EID: 33750427890     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.20621     Document Type: Article

References (42)

1. Alway SE, Degens H, Krishnamurthy G, Smith CA. Potential role for 1d myogenic repressors in apoptosis and attenuation of hypertrophy in muscles of aged rats. Am J Physiol Cell Physiol 2002;283:C66-C76.
2. Andersen JL, Terzis G, Kryger A. Increase in the degree of coexpression of myosin heavy chain isoforms in skeletal muscle fibers of the very old. Muscle Nerve 1999;22:449-454.
3. Andres PL, Thibodeau LM, Finison LJ, Munsat TL. Quantitative assessment of neuromuscular deficit in ALS. Neurol Clin 1987;5:125-141.
4. Aoki MS, Lima WP, Miyabara EH, Gouveia CH, Moriscot AS. Deleterious effects of immobilization upon rat skeletal muscle: role of creatine supplementation. Clin Nutr 2004;23:1176-1183.
5. Birouk N, LeGuern E, Maisonobe T, Rouger H, Gouider R, Tardieu S, et al. X-linked Charcot-Marie-Tooth disease with connexin 32 mutations: clinical and electrophysiologic study. Neurology 1998;50:1074-1082.
6. Caiozzo VJ, Baker MJ, Huang K, Chou H, Wu YZ, Baldwin KM. Single-fiber myosin heavy chain polymorphism: how many patterns and what proportions? Am J Physiol Regul Integr Comp Physiol 2003;285:R570-R580.
7. Campos GE, Luecke TJ, Wendeln HK, Toma K, Hagerman FC, Murray TF, et al. Muscular adaptations in response to three different resistance-training regimens: specificity of repetition maximum training zones. Eur J Appl Physiol 2002;88:50-60.
8. Chetlin RD, Gutmann L, Tarnopolsky M, Ullrich IH, Yeater RA. Resistance training effectiveness in patients with Charcot-Marie-Tooth disease: recommendations for exercise prescription. Arch Phys Med Rehabil 2004;85:1217-1223.
9. Chetlin RD, Gutmann L, Tarnopolsky MA, Ullrich IH, Yeater RA. Resistance training exercise and creatine in patients with Charcot-Marie-Tooth disease. Muscle Nerve 2004;30:69-76.
10. Csuka M, McCarty DJ. Simple method for measurement of lower extremity muscle strength. Am J Med 1985;78:77-81.
11. Dangott B, Schultz E, Mozdziak PE. Dietary creatine monohydrate supplementation increases satellite cell mitotic activity during compensatory hypertrophy. Int J Sports Med 2000;21:13-16.
12. Degens H, Yu F, Li X, Larsson L. Effects of age and gender on shortening velocity and myosin isoforms in single rat muscle fibres. Acta Physiol Scand 1998;163:33-40.
13. Florence JM, Hagberg JM. Effect of training on the exercise responses of neuromuscular disease patients. Med Sci Sports Exerc 1984;16:460-465.
14. Gill TM, Richardson ED, Tinetti ME. Evaluating the risk of dependence in activities of daily living among community-living older adults with mild to moderate cognitive impairment. J Gerontol A Biol Sci Med Sci 1995;50:M235-M241.
15. Grandis M, Shy ME. Current Therapy for Charcot-Marie-Tooth Disease. Curr Treat Options Neurol 2005;7:23-31.
16. Greenhaff PL, Bodin K, Soderlund K, Hultman E. Effect of oral creatine supplementation on skeletal muscle phosphocreatine resynthesis. Am J Physiol 1994;266:E725-E730.
17. Hespel P, Op't EB, Van Leemputte M, Urso B, Greenhaff PL, Labarque V, Dymarkowski S, et al. Oral creatine supplementation facilitates the rehabilitation of disuse atrophy and alters the expression of muscle myogenic factors in humans. J Physiol (Lond) 2001;536:625-633.
18. Hultman E, Soderlund K, Timmons JA, Cederblad G, Greenhaff PL. Muscle creatine loading in men. J Appl Physiol 1996;81:232-237.
19. Kilmer DD. Response to resistive strengthening exercise training in humans with neuromuscular disease. Am J Phys Med Rehabil 2002;81(suppl):S121- S126.
20. Klitgaard H, Bergman O, Betto R, Salviati G, Schiaffino S, Clausen T, Saltin B. Co-existence of myosin heavy chain I and IIa isoforms in human skeletal muscle fibres with endurance training. Pflugers Arch 1990;416:470-472.
21. Lange KH, Andersen JL, Beyer N, Isaksson F, Larsson B, Rasmussen MH, et al. GH administration changes myosin heavy chain isoforms in skeletal muscle but does not augment muscle strength or hypertrophy, either alone or combined with resistance exercise training in healthy elderly men. J Clin Endocrinol Metab 2002;87:513-523.
22. Lindeman E, Spaans F, Reulen J, Leffers P, Drukker J. Progressive resistance training in neuromuscular patients. Effects on force and surface EMG. J Electromyogr Kinesiol 1999;9:379-384.
23. Mazzaro N, Grey MJ, Sinkjaer T, Andersen JB, Pareyson D, Schieppati M. Lack of on-going adaptations in the soleus muscle activity during walking in patients affected by large-fiber neuropathy. J Neurophysiol 2005;93:3075-3085.
24. McCormick KM, Schultz E. Role of satellite cells in altering myosin expression during avian skeletal muscle hypertrophy. Dev Dyn 1994;199:52-63.
25. Parry DJ. Myosin heavy chain expression and plasticity: role of myoblast diversity. Exerc Sport Sci Rev 2001;29:175-179.
26. Pfeiffer G, Wicklein EM, Ratusinski T, Schmitt L, Kunze K. Disability and quality of life in Charcot-Marie-Tooth disease type I. J Neurol Neurosurg Psychiatry 2001;70:548-550.
27. Roman WJ, Alway SE. Stretch-induced transformations in myosin expression of quail anterior latissimus dorsi muscle. Med Sci Sports Exerc 1995;27:1494-1499.
28. Roman WJ, Fleckenstein J, Stray-Gundersen J, Alway SE, Peshock R, Gonyea WJ. Adaptations in the elbow flexors of elderly males after heavy-resistance training. J Appl Physiol 1993;74:750-754.
29. Schwid SR, Thornton CA, Pandya S, Manzur KL, Sanjak M, Petrie MD, et al. Quantitative assessment of motor fatigue and strength in MS. Neurology 1999;53:743-750.
30. Sowden JE, Logigian EL, Malik K, Herrmann DN. Genotype-phenotype correlation in a family with late onset CMT and an MPZ lys236del mutation. J Neurol Neurosurg Psychiatry 2005;76:442-444.
31. Suter U, Scherer SS. Disease mechanisms in inherited neuropathies. Nat Rev Neurosci 2003;4:714-726.
32. Szabo A, Zuchner S, Siska E, Mechler F, Molnar MJ. Marked phenotypic variation in a family with a new myelin protein zero mutation. Neuromuscul Disord 2005;15:760-763.
33. Taes YE, Speeckaert M, Bauwens E, De Buyzere MR, Libbrecht J, Lameire NH, et al. Effect of dietary creatine on skeletal muscle myosin heavy chain isoform expression in an animal model of uremia. Nephron Exp Nephrol 2004;96:e103-e110.
34. Tarnopolsky M, Mahoney D, Thompson T, Naylor H, Doherty TJ. Creatine monohydrate supplementation does not increase muscle strength, lean body mass, or muscle phosphocreatine in patients with myotonic dystrophy type I. Muscle Nerve 2004;29:51-58.
35. Tarnopolsky M, Martin J. Creatine monohydrate increases strength in patients with neuromuscular disease. Neurology 1999;52:854-857.
36. Telerman-Toppet N, Coers C. Motor innervation and fiber type pattern in amyotrophic lateral sclerosis and in Charcot-Marie-Tooth disease. Muscle Nerve 1978;1:133-139.
37. Verhamme C, van Schaik IN, Koelman JH, de Haan RJ, Vermeulen M, de Visser M. Clinical disease severity and axonal dysfunction in hereditary motor and sensory neuropathy Ia. J Neurol 2004;251:1491-1497.
38. Wallimann T, Hemmer W. Creatine kinase in non-muscle tissues and cells. Mol Cell Biochem 1994;133:193-220.
39. Wallimann T, Wyss M, Brdiczka D, Nicolay K, Eppenberger HM. Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the 'phosphocreatine circuit' for cellular energy homeostasis. Biochem J 1992;281:21-40.
40. Weimer LH, Podwall D. Medication-induced exacerbation of neuropathy in Charcot Marie Tooth disease. J Neurol Sci 2006;242:47-54.
41. Weiner DK, Long R, Hughes MA, Chandler J, Studenski S. When older adults face the chair-rise challenge. A study of chair height availability and height-modified chair-rise performance in the elderly. J Am Geriatr Soc 1993;41:6-10.
42. Willoughby DS, Rosene J. Effects of oral creatine and resistance training on myosin heavy chain expression. Med Sci Sports Exerc 2001;33:1674-1681.